发明名称 AEROSOL FORMULATIONS OF BUTALBITAL, LORAZEPAM, IPRATROPIUM, BACLOFEN, MORPHINE AND SCOPOLAMINE
摘要 A liquid aerosol formulation comprising at least one thermally stable active ingredient selected from the group consisting of butalbital, lorazepam, ipratropium, baclofen, morphine, scopolamine, pharmaceutically acceptable salts and esters thereof and derivatives thereof. The liquid formulation can include an organic solvent such as propylene glycol and one or more optional excipients. The active ingredient can be present in an amount of 0.01 to 5 weight percent and the formulation can be heated to provide a vapor which forms an aerosol having a mass median aerodynamic diameter of less than 3 µm.
申请公布号 WO2005037949(A3) 申请公布日期 2006.01.12
申请号 WO2004US32449 申请日期 2004.10.04
申请人 CHRYSALIS TECHNOLOGIES INCORPORATED;BLONDINO, FRANK, E.;POKLIS, JUSTIN;BAKER, MATTHEW 发明人 BLONDINO, FRANK, E.;POKLIS, JUSTIN;BAKER, MATTHEW
分类号 A61K9/00;A61K31/197;A61K31/46;A61K31/4745;A61K31/485;A61K31/513;A61K31/5513;A61K47/10;A61L9/04;A61M11/04 主分类号 A61K9/00
代理机构 代理人
主权项
地址